サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1462909

エクソソーム診断と治療市場：製品別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024-2032年）

Exosome Diagnostic and Therapeutic Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 269 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.78円
エクソソーム診断と治療市場：製品別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024-2032年）
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

エクソソーム診断と治療市場の規模は2023年に4億7,601万米ドルとなり、2024年から2032年にかけてCAGR 28.5％で拡大すると予測されています。

エクソソーム診断と治療市場 - 市場力学

心血管疾患の有病率の増加が市場需要を促進

エクソソーム診断・治療製品の市場は、心血管疾患の罹患率の増加により拡大しています。この背景には、長寿命で技術的に洗練された機器の進歩があります。心血管疾患の主な原因としては、食生活の乱れ、タバコの使用、運動不足が挙げられ、これらはすべて血圧や血糖値を上昇させ、体重過多や肥満につながります。WHOによれば、心血管系死亡者の5人に4人は心臓発作と脳卒中であり、その3分の1は70歳未満で早死にします。その結果、予測期間中、エクソソーム診断と治療市場はより速い速度で成長すると予想されます。

エクソソーム診断と治療市場 - 主要インサイト

アナリストが共有した分析によると、世界市場は予測期間（2024 - 2032年）に約28.5％のCAGRで毎年成長すると予測されています。

製品セグメンテーションに基づくと、試薬セグメントが予測期間で市場を独占すると予測されます。

アプリケーション別では、診断分野が予測期間中に市場成長をリードすると予測されます。

エンドユーザーセグメンテーションでは、がん研究所セグメントが予測期間中最大の市場シェアを占めると予測されます。

地域別では、北米が2023年の売上高をリードしました。

エクソソーム診断と治療市場 - セグメンテーション分析

世界のエクソソーム診断と治療市場は、製品、用途、エンドユーザー、地域に基づいて区分されます。

製品に基づき、市場は機器、試薬、ソフトウェアに分類されます。試薬分野は、診断目的の研究開発努力の増加や分子診断の必要性の高まりにより、予測期間中に市場を独占すると予想されます。

アプリケーション別に見ると、市場は診断用と治療用に分けられます。診断分野は、慢性疾患の有病率の上昇と早期診断の必要性の高まりにより、予測期間中に市場の成長をリードすると予想されます。

エンドユーザー別では、がん研究所、病院、診断センター、その他に分けられます。がん研究所セグメントが予測期間中最大の市場シェアを占めると予想されます。このセグメントの成長は、がん有病率の増加、病院数の増加、ヘルスケアインフラ開発のための政府プログラムの急増に起因しています。

エクソソーム診断と治療市場 - 地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は予測期間中、市場シェアの大半を占めると予想されています。この地域の市場拡大は、がん、心血管、糖尿病などの慢性疾患の有病率の増加に起因しています。例えば、米国がん協会の推計によると、2022年には米国で新たに190万人のがん患者が診断され、60万9360人が死亡すると予測されています。したがって、前述の統計が市場成長の原動力となっています。

エクソソーム診断と治療市場 - 競合情勢

市場の主要プレーヤーは、製品の発売、拡大、投資、コラボレーション、および市場の最大シェアを得るために様々な戦略を採用しました。

目次

第1章 エキソソーム診断と治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 エキソソーム診断と治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 エクソソーム診断と治療の産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長プロセスマッピング
  • フレームワーク分析

第5章 エキソソーム診断と治療市場：COVID-19の影響分析

  • COVID - 19以前の影響分析
  • COVID - 19後の影響分析

第6章 エキソソーム診断と治療市場情勢

  • エクソソーム診断と治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存プレイヤーの分析
    • 新興プレーヤーの分析

第7章 エキソソーム診断と治療市場 - 製品別

  • 概要
    • 製品別セグメントシェア分析
    • 機器
    • 試薬
    • ソフトウェア

第8章 エクソソーム診断と治療市場 - 用途別

  • 概要
    • アプリケーション別セグメントシェア分析
    • 診断
    • 治療

第9章 エキソソーム診断と治療市場 - エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • がん研究所
    • 病院
    • 診断センター
    • その他

第10章 エクソソーム診断と治療市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - エクソソーム診断と治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • NX Pharmagen, Inc.
    • Capricor Therapeutics, Inc.
    • System Biosciences, Inc.
    • NanoSomix, Inc
    • Thermo Fisher Scientific, Inc.
    • Exiqon A/S
    • Aethlon Medical, Inc.
    • Malvern Instruments Ltd
    • Sistemic Ltd
    • Exosome Diagnostic, Inc.

第12章 アナリストの見解

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Exosome Diagnostic and Therapeutic Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Exosome Diagnostic and Therapeutic Market, by Product 2019-2032 (USD Million)
  • TABLE Exosome Diagnostic and Therapeutic Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Exosome Diagnostic and Therapeutic Market, by Application 2019-2032 (USD Million)
  • TABLE Exosome Diagnostic and Therapeutic Market: End UserSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Exosome Diagnostic and Therapeutic Market, by End User2019-2032 (USD Million)
  • TABLE Exosome Diagnostic and Therapeutic Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Exosome Diagnostic and Therapeutic Market, by Region 2019-2032 (USD Million)
  • TABLE North America Exosome Diagnostic and Therapeutic Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Exosome Diagnostic and Therapeutic Market, by Product, 2019-2032 (USD Million)
  • TABLE North America Exosome Diagnostic and Therapeutic Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Exosome Diagnostic and Therapeutic Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Exosome Diagnostic and Therapeutic Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Exosome Diagnostic and Therapeutic Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe Exosome Diagnostic and Therapeutic Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Exosome Diagnostic and Therapeutic Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Exosome Diagnostic and Therapeutic Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Exosome Diagnostic and Therapeutic Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific Exosome Diagnostic and Therapeutic Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Exosome Diagnostic and Therapeutic Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Exosome Diagnostic and Therapeutic Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Exosome Diagnostic and Therapeutic Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America Exosome Diagnostic and Therapeutic Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Exosome Diagnostic and Therapeutic Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Exosome Diagnostic and Therapeutic Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Exosome Diagnostic and Therapeutic Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2367

REPORT HIGHLIGHT

Exosome Diagnostic and Therapeutic Market size was valued at USD 476.01 Million in 2023, expanding at a CAGR of 28.5% from 2024 to 2032.

The membrane-bound vesicle known as an exosome is produced in the extracellular space of eukaryotic cells. Applications of exosomes include immunological responses, viral pathogenicity, cardiovascular disease, diseases of the central nervous system, and the advancement of cancer. Exosomes efficiently transport biomolecules such as proteins, metabolites, and nucleic acids into target cells to modify their biological response. With the capacity to target specific targets, exosomes are designed to carry a variety of therapeutic payloads, such as immune modulators, chemotherapeutic drugs, antisense oligonucleotides, and short interfering RNAs. Liquid biopsy based on exosome vesicles has the potential to be employed in the diagnosis and prognostication of cancer and other diseases.

Exosome Diagnostic and Therapeutic Market- Market Dynamics

Increasing prevalence of cardiovascular disease to propel market demand

The market for exosome diagnostic and therapeutic products is expanding due to the increased incidence of cardiovascular disorders. This is ascribed to the advancement of long-lasting, technologically sophisticated equipment. Among the main causes of cardiovascular disease are a poor diet, tobacco use, and a lack of physical activity, all of which increase blood pressure and blood sugar levels, leading to overweight and obesity. Heart attacks and strokes account for four out of every five cardiovascular fatalities, according to the WHO, with one-third of these deaths occurring prematurely in those under the age of 70. Consequently, during the projected period, the Exosome Diagnostic and Therapeutic Market is expected to grow at a faster rate.

Exosome Diagnostic and Therapeutic Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 28.5% over the forecast period (2024-2032)

Based on product segmentation, the Reagent segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Diagnostic segment is expected to lead the market growth during the forecast period

Based on end user segmentation, the Cancer Institute segment is expected to hold the largest market share over the projected period

Based on region, North America was the leading revenue generator in 2023

Exosome Diagnostic and Therapeutic Market- Segmentation Analysis:

The Global Exosome Diagnostic and Therapeutic Market is segmented based on Product, Application, End User, and Region.

Based on the product, the market is categorized into Instrument, Reagent and Software. The Reagent segment is expected to dominate the market over the forecast period due to the rise in R&D efforts for diagnostic purposes as well as the growing necessity for molecular diagnosis.

Based on the application, the market is divided into Diagnostic and Therapeutic. The Diagnostic segment is expected to lead the market growth during the forecast period due to the rise in the prevalence of chronic illnesses and the increased need for early diagnosis.

Based on the end user, the industry is divided into Cancer Institute, Hospital, Diagnostic Center and Others. The Cancer Institute segment is expected to hold the largest market share over the projected period. The segment growth is attributable to increase in the prevalence of cancer, increase in the number of hospitals, and spike in government programs for the development of healthcare infrastructure.

Exosome Diagnostic and Therapeutic Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the majority of market share during the forecast period. The regional market expansion is attributed to the growing prevalence of chronic disease such as cancer, cardiovascular, diabetes and others. For instance, in 2022, there will be an anticipated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States, according to the American Cancer Society's estimates. Thus, the aforementioned stats drives the market growth.

Exosome Diagnostic and Therapeutic Market- Competitive Landscape:

The key players in the market are NX Pharmagen, Inc., Capricor Therapeutics, Inc., System Biosciences, Inc., NanoSomix, Inc, Thermo Fisher Scientific, Inc., Exiqon A/S, Aethlon Medical, Inc., Malvern Instruments Ltd, Sistemic Ltd and Exosome Diagnostic, Inc. These players adopted various strategies such as product launch, expansion, investment, collaboration, and others to obtain the maximum market share of the market.

Recent Developments:

In January 2024, the MassivEVTM EV Purification Column PS and MassivEVTM Purification Buffer Set, products made for high-purity and high-efficiency mass purification of extracellular vesicles (EVs) to promote exosome research, were recently introduced by FUJIFILM Wako Pure Chemical Corporation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

NX Pharmagen, Inc.

Capricor Therapeutics, Inc.

System Biosciences, Inc.

NanoSomix, Inc

Thermo Fisher Scientific, Inc.

Exiqon A/S

Aethlon Medical, Inc.

Malvern Instruments Ltd

Sistemic Ltd

Exosome Diagnostic, Inc.

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instrument
  • Reagent
  • Software

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic
  • Therapeutic

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Cancer Institute
  • Hospital
  • Diagnostic Center
  • Others

GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Exosome Diagnostic and Therapeutic Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Exosome Diagnostic and Therapeutic Market Snippet by Product
    • 2.1.2.Exosome Diagnostic and Therapeutic Market Snippet by Application
    • 2.1.3.Exosome Diagnostic and Therapeutic Market Snippet by End User
    • 2.1.4.Exosome Diagnostic and Therapeutic Market Snippet by Country
    • 2.1.5.Exosome Diagnostic and Therapeutic Market Snippet by Region
  • 2.2.Competitive Insights

3.Exosome Diagnostic and Therapeutic Key Market Trends

  • 3.1.Exosome Diagnostic and Therapeutic Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Exosome Diagnostic and Therapeutic Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Exosome Diagnostic and Therapeutic Market Opportunities
  • 3.4.Exosome Diagnostic and Therapeutic Market Future Trends

4.Exosome Diagnostic and Therapeutic Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Exosome Diagnostic and Therapeutic Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Exosome Diagnostic and Therapeutic Market Landscape

  • 6.1.Exosome Diagnostic and Therapeutic Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Exosome Diagnostic and Therapeutic Market - By Product

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2.Instrument
    • 7.1.3.Reagent
    • 7.1.4.Software

8.Exosome Diagnostic and Therapeutic Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Diagnostic
    • 8.1.3.Therapeutic

9.Exosome Diagnostic and Therapeutic Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Cancer Institute
    • 9.1.3.Hospital
    • 9.1.4.Diagnostic Center
    • 9.1.5.Others

10.Exosome Diagnostic and Therapeutic Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Exosome Diagnostic and Therapeutic Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Exosome Diagnostic and Therapeutic Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Exosome Diagnostic and Therapeutic Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Exosome Diagnostic and Therapeutic Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Exosome Diagnostic and Therapeutic Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Exosome Diagnostic and Therapeutic Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.NX Pharmagen, Inc.
    • 11.2.2.Capricor Therapeutics, Inc.
    • 11.2.3.System Biosciences, Inc.
    • 11.2.4.NanoSomix, Inc
    • 11.2.5.Thermo Fisher Scientific, Inc.
    • 11.2.6.Exiqon A/S
    • 11.2.7.Aethlon Medical, Inc.
    • 11.2.8.Malvern Instruments Ltd
    • 11.2.9.Sistemic Ltd
    • 11.2.10.Exosome Diagnostic, Inc.

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research End Userology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us